মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

wilshire pharmaceuticals - ciprofloxacin (unii: 5e8k9i0o4u) (ciprofloxacin - unii:5e8k9i0o4u), fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - ciprofloxacin and fluocinolone acetonide otic solution is indicated for the treatment of acute otitis media with tympanostomy tubes (aomt) in pediatric patients (aged 6 months and older) due to staphylococcus aureus , streptococcus pneumoniae , haemophilus influenzae , moraxella catarrhalis , and pseudomonas aeruginosa . ciprofloxacin and fluocinolone acetonide otic solution is contraindicated in: - patients with known hypersensitivity to fluocinolone acetonide or other corticosteroids, ciprofloxacin or other quinolones, or to any other components of ciprofloxacin and fluocinolone acetonide otic solution. - viral infections of the external ear canal, including varicella and herpes simplex infections and fungal otic infections. risk summary ciprofloxacin and fluocinolone acetonide otic solution is negligibly absorbed following otic administration and maternal use is not expected to result in fetal exposure to ciprofloxacin and fluocinolone acetonide [see clinical pharmacology (12.3)]. risk summary ciprofloxaci

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

xspire pharma, llc - ciprofloxacin (unii: 5e8k9i0o4u) (ciprofloxacin - unii:5e8k9i0o4u), fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - ciprofloxacin and fluocinolone acetonide otic solution is indicated for the treatment of acute otitis media with tympanostomy tubes (aomt) in pediatric patients (aged 6 months and older) due to staphylococcus aureus , streptococcus pneumoniae , haemophilus influenzae , moraxella catarrhalis , and pseudomonas aeruginosa . ciprofloxacin and fluocinolone acetonide otic solution is contraindicated in: - patients with known hypersensitivity to fluocinolone acetonide or other corticosteroids, ciprofloxacin or other quinolones, or to any other components of ciprofloxacin and fluocinolone acetonide otic solution. - viral infections of the external ear canal, including varicella and herpes simplex infections and fungal otic infections. risk summary ciprofloxacin and fluocinolone acetonide otic solution is negligibly absorbed following otic administration and maternal use is not expected to result in fetal exposure to ciprofloxacin and fluocinolone acetonide [see clinical pharmacology (12.3)]. risk summary ciprofloxacin and fluocinolone acetonide otic solution is negligibly absorbed by the mother following otic administration and breastfeeding is not expected to result in exposure of the infant to ciprofloxacin and fluocinolone acetonide [ see clinical pharmacology (12.3) ]. ciprofloxacin and fluocinolone acetonide otic solution has been studied in patients as young as 6 months in adequate and well-controlled clinical trials. no major differences in safety and effectiveness have been observed between adult and pediatric patients [ see indications and usage (1)and dosage and administration (2)]. clinical studies of ciprofloxacin and fluocinolone acetonide otic solution did not include sufficient numbers of subjects aged 65 years and over to determine whether they respond differently from younger subjects. other reported clinical experience has not identified differences in responses between the elderly and younger patients. read this instructions for use that comes with ciprofloxacin and fluocinolone acetonide otic solution before you start using it and each time you get a refill. there may be new information. this information does not take the place of talking with your healthcare provider about your medical condition or treatment. important information about ciprofloxacin and fluocinolone acetonide otic solution : - ciprofloxacin and fluocinolone acetonide otic solution is for use in the ear only (otic use) . do not inject ciprofloxacin and fluocinolone acetonide otic solution or use ciprofloxacin and fluocinolone acetonide otic solution in the eye. - use ciprofloxacin and fluocinolone acetonide otic solution exactly as your healthcare provider tells you to use it. how should i use ciprofloxacin and fluocinolone acetonide otic solution? this instructions for use has been approved by the food and drug administration.

বেলজিয়াম - ইংরেজি - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

alimera sciences europe ltd. - fluocinolone acetonide 0,19 mg - intravitreal implant in applicator - 190 µg - fluocinolone acetonide 0.19 mg - fluocinolone acetonide

কানাডা - ইংরেজি - Health Canada

hill dermaceuticals inc - fluocinolone acetonide - emulsion - 0.01% - fluocinolone acetonide 0.01% - anti-inflammatory agents

কানাডা - ইংরেজি - Health Canada

bausch health, canada inc. - fluocinolone acetonide - solution - 0.01% - fluocinolone acetonide 0.01% - anti-inflammatory agents

কানাডা - ইংরেজি - Health Canada

bausch health, canada inc. - fluocinolone acetonide - ointment - 0.025% - fluocinolone acetonide 0.025% - anti-inflammatory agents

কানাডা - ইংরেজি - Health Canada

hill dermaceuticals inc - fluocinolone acetonide - solution - 0.01% - fluocinolone acetonide 0.01% - corticosteroids

কানাডা - ইংরেজি - Health Canada

bausch & lomb inc - fluocinolone acetonide - implant - 0.59mg - fluocinolone acetonide 0.59mg - corticosteroids

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

arbor pharmaceuticals - ciprofloxacin (unii: 5e8k9i0o4u) (ciprofloxacin - unii:5e8k9i0o4u), fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - ciprofloxacin 872.5 ug in 0.25 ml - otovel is indicated for the treatment of acute otitis media with tympanostomy tubes (aomt) in pediatric patients (aged 6 months and older) due to staphylococcus aureus, streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, and pseudomonas aeruginosa . otovel is contraindicated in: - patients with known hypersensitivity to fluocinolone acetonide or other corticosteroids, ciprofloxacin or other quinolones, or to any other components of otovel. - viral infections of the external ear canal, including varicella and herpes simplex infections and fungal otic infections. risk summary otovel is negligibly absorbed following otic administration and maternal use is not expected to result in fetal exposure to ciprofloxacin and fluocinolone acetonide [see clinical pharmacology (12.3) ]. risk summary otovel is negligibly absorbed by the mother following otic administration and breastfeeding is not expected to result in exposure of the infant to ciprofloxacin and fluocinolone acetonide [see clinical phar

কানাডা - ইংরেজি - Health Canada

knight therapeutics inc. - fluocinolone acetonide - implant - 0.19mg - fluocinolone acetonide 0.19mg - corticosteroids